IL-1RA protein expression decreases progressively during oral carcinogenesis and in HNSCC [65], which is in agreement with a previous report [80] and IL-1R2, the other IL-1 inhibitor, is not able to compensate for IL-1RA lack of expression [65]. Here, IL1B is linked to head and neck squamous cell carcinoma.